It is not a matter of weather or not LTC has a superior product as I believe they do. But what I have a hard time believing is that in this market of cut-backs and health care reform, LTC can convince enough surgeons to replace what they are already using for "duct and vessel sealing", at a competitive price that will also be profitable for CTGI.
I am just not convinced that surgeons are looking for a better duct and vessel sealing device. It is hard to get people to change without showing them a drastic benefit.
To illustrate my point, I have followed several "best in class" stocks that have been struggling for several years trying to get market acceptance. One is a dentist drill replacement using laser. I keep watching them and they will probably have their day but it is a long road to market penetration even when they are a NASDAQ stock.